IRIS - Res&Arch Institutional Research Information System - Research & Archive

DI FILIPPO, MASSIMILIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.271
EU - Europa 1.899
AS - Asia 745
SA - Sud America 5
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.926
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.266
IE - Irlanda 481
IT - Italia 411
UA - Ucraina 242
HK - Hong Kong 239
SE - Svezia 226
SG - Singapore 178
CN - Cina 138
VN - Vietnam 121
FR - Francia 103
FI - Finlandia 94
RU - Federazione Russa 93
DE - Germania 75
RO - Romania 46
GB - Regno Unito 37
CZ - Repubblica Ceca 34
KR - Corea 24
BE - Belgio 17
JP - Giappone 14
NL - Olanda 12
CH - Svizzera 9
TR - Turchia 9
GR - Grecia 7
LB - Libano 7
MX - Messico 5
UZ - Uzbekistan 5
AT - Austria 4
EG - Egitto 4
IR - Iran 3
PH - Filippine 3
PL - Polonia 3
BR - Brasile 2
CO - Colombia 2
EU - Europa 2
RS - Serbia 2
CL - Cile 1
ES - Italia 1
IN - India 1
LV - Lettonia 1
MN - Mongolia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 4.926
Salva come PNG Salva come JPEG
Città #
Chandler 512
Dublin 481
Hong Kong 238
San Mateo 219
Perugia 168
Altamura 139
Jacksonville 130
Dong Ket 121
Medford 111
Princeton 110
Singapore 107
Lawrence 105
Wilmington 93
Andover 86
Ann Arbor 81
Beijing 68
Des Moines 60
Boardman 58
Redmond 40
Falls Church 34
Bucharest 33
Brno 27
Saint Petersburg 25
Los Angeles 24
Seoul 24
Helsinki 20
Norwalk 19
Ashburn 18
Redwood City 18
Brussels 17
Woodbridge 17
Tokyo 14
Timisoara 12
Moscow 11
Munich 11
Den Haag 9
Izmir 9
San Paolo di Civitate 9
Chicago 5
Houston 5
Olomouc 5
Sinnai 5
Foligno 4
Lappeenranta 4
Pomezia 4
Terni 4
Verona 4
Dasmarinas 3
Giza 3
Milan 3
Auburn Hills 2
Bogotá 2
Fairfield 2
Florence 2
Frankfurt am Main 2
Fremont 2
Genoa 2
Hamburg 2
Mondolfo 2
Nagold 2
New York 2
Padova 2
Paris 2
Shanghai 2
Strongoli 2
Tappahannock 2
Turin 2
Utrecht 2
Baltimore 1
Bloomfield 1
Bollebygd 1
Brescia 1
Buffalo 1
Böblingen 1
Cambridge 1
Changsha 1
Chiaravalle 1
Dearborn 1
Derio 1
Edinburgh 1
Groningen 1
Hsinchu 1
Kalngale 1
Lausanne 1
Ludwigshafen am Rhein 1
Maceió 1
Mexico City 1
Mogi Guacu 1
Mogliano 1
Monte Urano 1
Monterrey 1
Montreuil 1
Monza 1
Nanjing 1
Napoli 1
Palermo 1
Parma 1
Pars 1
Phoenix 1
Piacenza 1
Totale 3.395
Salva come PNG Salva come JPEG
Nome #
Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit 145
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration 105
Synaptic plasticity and experimental autoimmune encephalomyelitis: implications for multiple sclerosis 91
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease. 81
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 78
Plasticity and repair in the post-ischemic brain 73
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation. 70
Basi neurobiologiche dei deficit cognitivi nella malattia di Parkinson 68
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 68
Ischemic bilateral hippocampal dysfunction during transient global amnesia. 67
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 67
Hippocampal epileptogenesis in autoimmune encephalitis 65
Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. 64
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 64
Mitochondria and the link between neuroinflammation and neurodegeneration. 61
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease 61
Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. 59
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 59
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity 59
Visual pathway involvement in multiple sclerosis: Look straight in the eyes 59
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 56
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis 56
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis 56
Critical role of calcitonin gene-related peptide receptors in cortical spreading depression. 55
Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism. 55
2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes 54
ACh/dopamine crosstalk in motor control and reward: a crucial role for alpha 6-containing nicotinic receptors? 53
Ischemic stroke injury is mediated by aberrant Cdk5 53
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 53
Endogenous 17β-estradiol is required for activity-dependent long-term potentiation in the striatum: interaction with the dopaminergic system 52
Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission. 51
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis (Scientific Reports (2016) 6 (20926) DOI: 10.1038/srep20926) 51
Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis. 50
Treatment of multiple sclerosis relapses with high-dose methylprednisolone reduces the evolution of contrast-enhancing lesions into persistent black holes 50
Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment. 49
Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency 49
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. 48
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 47
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 47
Distinct levels of dopamine denervation differentially alter striatal synapticplasticity and NMDA receptor subunit composition. 46
A pathophysiological link between dystonia, striatal interneurons and neuropeptide Y 46
Lacosamide protects striatal and hippocampal neurons from in vitro ischemia without altering physiological synaptic plasticity 46
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition 46
The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease. 45
Beyond clinical changes: Rehabilitation-induced neuroplasticity in MS 45
Retinopathy during interferon-β treatment for multiple sclerosis: case report and review of the literature 45
Direct and indirect pathways of basal ganglia: a critical reappraisal. 44
A young patient with type C multiple system atrophy and hereditary hemochromatosis. 44
Pathways of neurodegeneration and experimental models of basal ganglia disorders: downstream effects of mitochondrial inhibition. 44
La disfunzione sessuale nei pazienti con sclerosi multipla: prevalenza e impatto dei trattamenti sintomatici 43
Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study 43
Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis 43
From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson’s Disease: Lessons From LRRK2 43
Heterozygous X-linked adrenoleukodystrophy-associated myelopathy mimicking primary progressive multiple sclerosis 42
Recurrent hyperCKemia with normal muscle biopsy in a pediatric patient with neuromyelitis optica 42
Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers 41
High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline 40
Na+/Ca2+ exchanger maintains ionic homeostasis in the peri-infarct area. 39
Multiple sclerosis and cognition: synaptic failure and network dysfunction 39
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 39
An “all-wheel drive” proposal to accelerate clinical research in common and rare neurological diseases 39
Tracing Neurological Diseases in the Presymptomatic Phase: Insights From Neurofilament Light Chain 39
Serum neurofilament light chain as a preclinical marker of neurodegeneration 38
Parkinsonism and cognitive impairment following chronic exposure to potassium cyanide. 37
The endocannabinoid system in Parkinson's disease. 37
Teaching NeuroImages: Acute tetraparesis: Mind the brain 37
CSF proteome analysis in multiple sclerosis patients by two-dimensional electrophoresis. 37
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 37
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 37
Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. 36
Lower urinary tract symptoms and urodynamic dysfunctions in clinically isolated syndromes suggestive of multiple sclerosis. 36
Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome. 36
Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia. 35
Infliximab monotherapy for neuro-Behçet's disease: a case report 35
Multiple sclerosis and chronic progressive external ophthalmoplegia associated with a large scale mitochondrial DNA single deletion 35
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis 35
Short-term and long-term plasticity at corticostriatal synapses: Implications for learning and memory. 33
Sensitization, glutamate, and the link between migraine and fibromyalgia. 33
Neuroscience: Brain's traffic lights. 33
A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance. 33
A blood test for Alzheimer's disease: a step forward 33
Epilepsy-induced abnormal striatal plasticity in Bassoon mutant mice. 33
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 33
Downstream mechanisms triggered by mitochondrial dysfunction in the basal ganglia: from experimental models to neurodegenerative diseases. 32
Synaptic dysfunction in multiple sclerosis: A red thread from inflammation to network disconnection 32
Dopamine-mediated regulation of corticostriatal synaptic plasticity. 32
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap. 31
Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia 31
Plastic abnormalities in experimental Huntington's disease. 31
Neurofilament light chain as a biomarker in neurological disorders 31
Molecular mechanisms underlying levodopa-induced dyskinesia. 31
Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics 31
Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients. 30
Synaptic plasticity, dopamine and Parkinson's disease: one step ahead. 30
Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes. 30
Epidemiologia, patogenesi e genetica. 30
Finding a way to preserve mitochondria: New pathogenic pathways in experimental multiple sclerosis 30
Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-beta 1a, and high doses of immunoglobulins. 29
Interferon-β1a modulates glutamate neurotransmission in the CNS through CaMKII and GluN2A-containing NMDA receptors 29
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 29
Totale 4.690
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.353
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.353
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020364 32 8 38 12 35 17 37 40 43 61 10 31
2020/2021749 8 35 23 38 249 50 45 30 63 25 50 133
2021/20221.041 13 158 34 46 49 31 13 290 21 82 158 146
2022/20231.742 119 373 23 152 124 188 6 58 627 4 51 17
2023/2024918 38 84 33 61 6 2 164 13 122 32 162 201
2024/202524 24 0 0 0 0 0 0 0 0 0 0 0
Totale 5.234